The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isNo placebo-controlled trial of this product exists, in any indication, in any country.
- What to watchHives or wheeze after a human-protein injection.
How Laennec works
This is the most expensive item in the catalog it comes from, and its own named literature is two rat papers from 1989. More than ten times most of the shelf and the only product on it no other partner carries.
What the material actually is. An enzymatic hydrolysate of pooled human placenta given by injection. Not a molecule, not a defined peptide, not a recombinant protein — a digest of donated human tissue, whose composition depends on the donors, the enzyme, the digestion time and the fractionation, none of which any vendor publishes.
Not a molecule and not a defined peptide: a digest of donated human tissue whose composition depends on the donors, the enzyme, the digestion time and the fractionation, none of which any vendor publishes. The proposal is that placental tissue is rich in growth factors, cytokines and nucleotides and that the hydrolysate delivers a regenerative mixture. No paper in this literature identifies an active constituent, assays it.
- Injectable
On the goal map: Liver, kidney, gut & lung (Organ-specific bioregulation)
Research on Laennec8 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Two rat papers from 1989 name Laennec itself. The human literature is about other manufacturers' placental extracts and contains no placebo-controlled trial.
Human clinical evidence
No placebo-controlled trial of this product exists, in any indication, in any country. The one properly blinded randomized trial in this class is a non-inferiority comparison of one placental extract against another with no placebo arm, scored on the Kupperman index, which by design cannot detect whether the class does anything (Kim 2023).
That trial found no significant difference in estradiol or follicle-stimulating hormone — which rules out the hormonal explanation most buyers assume.
Correlative data
The only human study of a placental extract with a control group randomized 39 community-dwelling Koreans aged 65+, 22 to subcutaneous extract and 17 to saline, single-blind, with a self-reported questionnaire as the outcome. Between groups, only the physical function subscale reached significance (p=0.036) (Kong 2012).
A 2025 editorial commentary describes human placental extract as promising in chronic liver disease (Liu 2025). An editorial is a considered opinion, not a dataset.
How the mechanism reads
An enzymatic hydrolysate of pooled human placenta given by injection — a digest of donated human tissue whose composition depends on the donors, the enzyme and the fractionation, none of which any vendor publishes.
MechanisticIts two named studies contradict each other about the route. The regeneration study concludes intravenous was much more potent than subcutaneous (Nakayama 1989a); the injury study concludes no therapeutic difference between them (Nakayama 1989b). Same laboratory, same year, and unresolved for thirty-seven years.
MechanisticBoth report it did NOT inhibit pseudolobule formation. Pseudolobules are the architectural distortion that defines cirrhosis. The enzymes moved and the disease-defining feature did not.
MechanisticPredicted risk class, not a reported event: a pooled human tissue product given parenterally raises donor screening, viral inactivation and batch traceability questions, and none of the published sources describes any of them.
Mechanistic
Sources
- Nakayama S, Kodama K, Oguchi K. Nihon Yakurigaku Zasshi 1989 [Japanese] · PMID 2613108
- Nakayama S, Yamauchi M, Oguchi K. Nihon Yakurigaku Zasshi 1989 [Japanese] · PMID 2807070
- Kong M, Park SB. Effect of human placental extract on health status in elderly Koreans. Evidence-Based Complementary and Alternative Medicine 2012 · PMID 22454680
- Kim S, Lee S, Ahn KH, Park HT, Song JY, Hong SC, Kim T. A randomized, multicenter, double-blind, parallel, non-inferiority clinical study comparing Unicenta and Melsmon for menopausal symptom improvement. Medicina (Kaunas) 2023 · PMID 37629679
- Liu Y, Wang Y, Yang XJ. Revitalizing liver health: human placental extract shows promise in chronic liver disease management. World Journal of Clinical Cases 2025 [editorial commentary] · PMID 41113079
Laennec safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Past reaction to a human-derived protein product.
- Planning to donate blood, because some countries bar donors who received placental extract.
- Hormone-sensitive cancer, as placental extracts carry hormones and growth factors.
- Immune suppression, since it is pooled donated human tissue.
- Pregnancy, as a pooled placental digest contains hormones and has no obstetric safety data.
What’s expected
- A tissue digest whose contents vary with donors and digestion.
- Pain, redness or a sting at the placement site.
- Flushing in some people.
Watch for
- Hives or wheeze after a human-protein injection.
- Fever and chills hours after the injection.
- Yellow skin.
Labs that tell you it’s working
- Comprehensive Metabolic Panel: liver enzymes, as placental hydrolysate has been studied in liver conditions.
- hs-CRP: shows an immune reaction to a human-derived tissue product.
- Complete Blood Count: eosinophils flag an allergic response.
Enzymatic hydrolysate of pooled human placenta given by injection: not a molecule, so risk is immunogenicity, composition drift and donor-borne infection. PMID 22454680 PMID 37629679 PMID 41113079
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Laennec FAQ4 common questions
- Is Laennec approved for human use?
- No. Laennec is a research compound.
- What is Laennec researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; hs-CRP; Complete Blood Count: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Laennec: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



